Werewolf Therapeutics HOWL
NASDAQ HOWL
$1.03 -0.02 (-1.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Werewolf Therapeutics (HOWL) Capital Expenditures (2020 - 2024)

Updated

Werewolf Therapeutics (HOWL) posted Capital Expenditures of $123,000 for Q4 2024, down 37.9% from $198,000 a year earlier.

Analysis

Werewolf Therapeutics (HOWL) Capital Expenditures (2020 - 2024) Analysis & Trends

For FY2024, Werewolf Therapeutics' Capital Expenditures came in at $254,000, down 67.0% from FY2023.

  • Annual Capital Expenditures shows a four-year compound annual growth rate of -17.9% (FY2020 to FY2024).
  • In prior years, Werewolf Therapeutics' Capital Expenditures was $769,000 in FY2023 (-78.7%), $3.61 million in FY2022 (+625.1%), $498,000 in FY2021 (-11.1%) and $560,000 in FY2020.
  • Quarterly Capital Expenditures has run from a low of $3,000 in Q3 2024 to a high of $1.95 million in Q3 2022 over five years.
  • On a year-over-year basis, Capital Expenditures has declined in each of the last seven quarters, with growth averaging 0.6% over the last eight quarters.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2022, with growth of 900.9%; the weakest was Q3 2024, with a decline of 98.6%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $3,000 (Q3 2024), $17,000 (Q2 2024) and $111,000 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Werewolf Therapeutics 49.57 Mn -141.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 123,000.00
Sep 30, 2024 3,000.00
Jun 30, 2024 17,000.00
Mar 31, 2024 111,000.00
Dec 31, 2023 198,000.00
Sep 30, 2023 221,000.00
Jun 30, 2023 182,000.00
Mar 31, 2023 168,000.00
Dec 31, 2022 518,000.00
Sep 30, 2022 1.95 Mn
Jun 30, 2022 1.11 Mn
Mar 31, 2022 28,000.00
Dec 31, 2021 272,000.00
Sep 30, 2021 102,000.00
Jun 30, 2021 111,000.00
Mar 31, 2021 13,000.00
Dec 31, 2020 9,000.00
Sep 30, 2020 57,000.00
Jun 30, 2020 45,000.00
Mar 31, 2020 449,000.00
API Access

Werewolf Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HOWL&period=max&api_key=YOUR_API_KEY